Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).
about
The metabolic syndrome in Africa: Current trendsMetabolic complications of androgen deprivation therapy for prostate cancerA multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretionInsulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivoGender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjectsCiprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewA mathematical model of the euglycemic hyperinsulinemic clamp.Perinatal overnutrition exacerbates adipose tissue inflammation caused by high-fat feeding in C57BL/6J miceTransamination is required for {alpha}-ketoisocaproate but not leucine to stimulate insulin secretionLuteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight womenTrans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin.Islet Hypersensitivity to Glucose Is Associated With Disrupted Oscillations and Increased Impact of Proinflammatory Cytokines in Islets From Diabetes-Prone Male Mice.RETRACTED: The SNARE protein SNAP23 and the SNARE-interacting protein Munc18c in human skeletal muscle are implicated in insulin resistance/type 2 diabetes.Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR).Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia.Using pre-existing microarray datasets to increase experimental power: application to insulin resistance.β-Cell failure in type 2 diabetes.One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study.Global transcriptome profiling identifies KLF15 and SLC25A10 as modifiers of adipocytes insulin sensitivity in obese womenInsulin: new roles for an ancient hormone.Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test.Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation."Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome?"Adiposity indices in the prediction of metabolic abnormalities associated with cardiovascular disease in non-diabetic adultsHypoglycemic effects and mechanisms of electroacupuncture on insulin resistanceTauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.Validation of obesity based on self-reported data in Spanish women participants in breast cancer screening programmesClustering of metabolic abnormalities in obese individuals: the role of genetic factors.Nonhuman primates and other animal models in diabetes research.Interleukin-1 beta: a potential link between stress and the development of visceral obesity.Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.Utility of obesity indicators for metabolically healthy obesity: an observational study using the Korean National Health and Nutrition Examination Survey (2009-2010).Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study.Is serum zinc level associated with prediabetes and diabetes?: a cross-sectional study from BangladeshVisceral obesity and metabolic syndrome.Metabolically healthy obesity and its associates in Mongolian Chinese adults.
P2860
Q24605049-F4E70407-FB4A-4A4B-AB10-7FF2F7EC0780Q24616159-98B2ABDC-E140-49B5-90A7-FF5289F5A864Q24678786-A328D2C1-278A-4A31-A5B4-4E7B67A7795CQ24683214-D2FE5F79-9947-4EB0-9F0B-D1627C471F33Q24796513-5462974E-E7B2-4199-843D-8B4072719F52Q24796775-937249D1-AC44-4363-8A2D-5950191EB585Q24801508-343391BD-B39F-4DDE-AE18-6CE25B6D1166Q24812253-82730272-006A-45A3-865A-2E625218F36EQ27310637-AFA12692-5777-47F1-9758-154D19C2D86BQ28291461-365238E5-DD0E-44F5-BA83-E47863869C6BQ28391267-9EFCE75E-B4D8-4601-B57A-0E089F2CDDAAQ28596552-CA37DE78-87FD-47A2-BF0E-AD769E43FAF6Q30277210-6C2B6E96-F7F6-4686-BC3C-C4C6C9860901Q30495722-5213D935-A527-464D-BBF5-25C1C80E5670Q31011189-B8E4E379-CA43-4ADB-A283-0C3A9EAF3D8FQ31901715-11AC908A-0BB9-4B9B-8EB8-97535C57BB6FQ33411879-EBC9F629-43DB-4650-9B0A-D3241EC4A2F8Q33548788-8959536C-06F3-446D-A4C1-800B8EB14B5BQ33588325-2F92BB7E-E033-4BBF-AF21-E7327A894DD3Q33678580-B1774268-97C2-4786-A831-00BD614FB446Q33751803-30744E25-082B-4827-868D-8E9D1496CEBEQ33785692-DF39EA7B-D228-4EF5-BFB5-F8FDA95F1A10Q33804310-22547943-C13D-4D58-BDD3-6F3407B04610Q33812357-23F53F58-3B4A-4EE0-B926-0EE3299A6149Q33910578-FB45DD51-1179-4E68-ABE2-18389A9E8887Q33955528-D034AC7A-CC4B-4911-831C-6B4BCBD673EDQ34001606-0A7B5671-794C-45D3-AE57-D15758E1BEE7Q34024266-B4FA3DCD-D153-498E-B0C0-B3CE50B43735Q34114545-1E204119-D14A-4124-94BE-9C9AAD2B9FE8Q34235218-373D1642-BB93-4A8C-9941-8A1A1CDCD48EQ34286456-D8ABC002-AC92-45DF-911C-3B2FC2752F39Q34318738-E9A2F59D-8BE3-4E62-9FE6-537BD3E8004CQ34344990-DE78A9A1-E8EC-4BFA-BA1F-C345909081BFQ34366918-964E2223-13D6-4907-8328-D74B8DB3BAE3Q34564316-8098F0CB-0CF8-42EE-95AE-6BA9AF8478D8Q34581577-766AA311-ADD1-4805-A685-5B206DFD893CQ34627340-166D7DBE-967F-439E-80AF-BD6241023E62Q34685087-8DE7B2C9-844D-4304-9C6A-E4D7ED4B9304Q34741883-8C9F0C10-2541-4C04-8AD7-B0AE8201AE61Q34768357-ABBEBB45-0AED-4C41-B169-5E6E21B1D8BE
P2860
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin resistance and hyperse ...... of Insulin Resistance (EGIR).
@en
Insulin resistance and hyperse ...... he Study of Insulin Resistance
@nl
type
label
Insulin resistance and hyperse ...... of Insulin Resistance (EGIR).
@en
Insulin resistance and hyperse ...... he Study of Insulin Resistance
@nl
prefLabel
Insulin resistance and hyperse ...... of Insulin Resistance (EGIR).
@en
Insulin resistance and hyperse ...... he Study of Insulin Resistance
@nl
P2093
P2860
P356
P1476
Insulin resistance and hyperse ...... y of Insulin Resistance (EGIR)
@en
P2093
E Ferrannini
G Mingrone
P Cavallo-Perin
P2860
P304
P356
10.1172/JCI119628
P407
P577
1997-09-01T00:00:00Z